Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:15:05.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the intervention details to include a verified status from June 2020 and added contact information for Dr. Sabine Zoechbauer-Mueller, while removing the previous intervention type and updating the revision to v2.14.0.
    Difference
    1%
    Check dated 2025-01-12T17:46:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:43:55.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-07T16:11:39.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature while removing detailed options related to participant groups, interventions, and various data fields for downloads.
    Difference
    5%
    Check dated 2024-11-23T04:36:49.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    Several key health-related websites, including MedlinePlus and DailyMed, have been removed from the monitored list, indicating a potential shift in focus or resource availability.
    Difference
    0.4%
    Check dated 2024-11-15T23:45:51.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.